Gunnar P.H. Dietz

Dr. Gunnar P.H. Dietz

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2002 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
Gunnar P.H. DietzGunnar P.H. Dietz
Gunnar P.H. Dietz
EKErtugrul Kilic
Ertugrul Kilic
MBMathias Bähr
Mathias Bähr

25 December 2007 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
FNFlorian Nagel
Florian Nagel
Björn FalkenburgerBjörn Falkenburger
Björn Falkenburger
Lars TöngesLars Tönges
Lars Tönges
SKSebastian Kowsky
Sebastian Kowsky
CPCharlotte Pöppelmeyer
Charlotte Pöppelmeyer
Gunnar P.H. DietzGunnar P.H. Dietz
Gunnar P.H. Dietz
Parkinson’s disease is characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra. The heat‐shock protein 70 (Hsp70) reduces protein misfolding and aggregation. It has been shown to protect cells against oxidative stress and apoptotic stimuli in various neurodegenerative disease models. To deliver Hsp70 across cellular membranes and into the brain, we linked it to a cell‐penetrating peptide derived from the HIV trans‐activator of transcription (Tat) protein. In vitro, Tat‐Hsp70 transduced neuroblastoma cells and protected primary mesencephalic DA neurons and their neurites against MPP+‐mediated degeneration. In vivo, the systemic application of cell‐permeable Hsp70 protected DA neurons of the substantia nigra pars compacta against subacute toxicity of MPTP. Furthermore, Tat‐Hsp70 diminished the MPTP induced decrease in DA striatal fiber density. Thus, we demonstrate that systemically applied Tat‐Hsp70 effectively prevents neuronal cell death in in vitro and in vivo models of Parkinson’s disease. The use of Tat‐fusion proteins might therefore be a valuable tool to deliver molecular chaperones like Hsp70 into the brain and may be the starting point for new protective strategies in neurodegenerative diseases.

11 October 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
ŽKŽarko Kulić
Žarko Kulić
MLMartin D. Lehner
Martin D. Lehner
Gunnar P.H. DietzGunnar P.H. Dietz
Gunnar P.H. Dietz
It is an often-neglected fact that extracts derived from the very same plant can differ significantly in their phytochemical composition, and thus also in their pharmacokinetic and pharmacodynamic properties which are the basis for their clinical efficacy and safety. TheGinkgo bilobaL. [Ginkgoaceae] special extract EGb 761®is one of the best-studied plant extracts in the world. In the present review, using that extract as a paradigm, we describe insights how climate, the harvest region, processing of the plant material, the drying process, the extraction solvents, and the details of the subsequent process steps substantially impact the quality and uniformity of the final extract. We highlight the importance of regulating active constituent levels and consistent reduction of undesired substances in herbal extracts. This is accomplished by a controlled production process and corresponding analytical specifications. In conclusion, since extracts derived from the same plant can have very different phytochemical compositions, results from pharmacological, toxicological and clinical studies gained with one specific extract cannot be extrapolated to other extracts that were generated using different production processes. We propose that the heterogenous nature of extracts should be meticulously considered when evaluating the efficacy and safety of plant-derived remedies.

1 February 2010 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
Gunnar P.H. DietzGunnar P.H. Dietz
Gunnar P.H. Dietz
Cell-penetrating peptides (CPP), also called protein transduction domains (PTD), membrane-permeable peptides (MPP), or Trojan horse peptides, have been used in many different research areas. The delivery of heat shock proteins (Hsp) using CPP has been applied in models for apoptosis, necrosis, oxidative stress, neurodegenerative diseases, stroke, cystic fibrosis, smooth muscle relaxation, myocardial injury, scar formation, and others. This review summarizes the accomplishments of the field over the last years and discusses why Hsp are particularly suitable for CPP-mediated delivery.

1 April 2006 in Brain Research
Verified
Journal Article
Closed access
Gunnar P.H. DietzGunnar P.H. Dietz
Gunnar P.H. Dietz
PVPaola C. Valbuena
Paola C. Valbuena
BDBirgit Dietz
Birgit Dietz
KMKatrin Meuer
Katrin Meuer
PMPatrick Müller
Patrick Müller
MBMathias Bähr
Mathias Bähr

1 December 2005 in Brain Research Bulletin
Verified
Journal Article
Closed access
Gunnar P.H. DietzGunnar P.H. Dietz
Gunnar P.H. Dietz
MBMathias Bähr
Mathias Bähr